Literature DB >> 11112520

Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1).

R Daoud1, C Kast, P Gros, E Georges.   

Abstract

The mechanisms of MRP1-drug binding and transport are not clear. In this study, we have characterized the interaction between MRP1 and rhodamine 123 (Rh123) using the photoreactive-iodinated analogue, [(125)I]iodoaryl azido-rhodamine 123 (or IAARh123). Photoaffinity labeling of plasma membranes from HeLa cells transfected with MRP1 cDNA (HeLa-MRP1) with IAARh123 shows the photolabeling of a 190 kDa polypeptide not labeled in HeLa cells transfected with the vector alone. Immunoprecipitation of a 190 kDa photolabeled protein with MRP1-sepcific monoclonal antibodies (QCRL-1, MRPr1, and MRPm6) confirmed the identity of this protein as MRP1. Analysis of MRP1-IAARh123 interactions showed that photolabeling of membranes from HeLa-MRP1 with increasing concentrations of IAARh123 was saturable, and was inhibited with excess of IAARh123. Furthermore, the photoaffinity labeling of MRP1 with IAARh123 was greatly reduced in the presence of excess Leukotreine C(4) or MK571, but to a lesser extent with excess doxorubicin, colchicine or chloroquine. Cell growth assays showed 5-fold and 14-fold increase in the IC(50) of HeLa-MRP1 to Rh123 and the Etoposide VP16 relative to HeLa cells, respectively. Analysis of Rh123 fluorescence in HeLa and HeLa-MRP1 cells with or without ATP suggests that cross-resistance to Rh123 is in part due to reduced drug accumulation in the cytosol of HeLa-MRP1 cells. Mild digestion of purified IAARh123-photolabeled MRP1 with trypsin showed two large polypeptides (approximately 111 and approximately 85 kDa) resulting from cleavage in the linker domain (L1) connecting the multiple-spanning domains MSD0 and MSD1 to MSD2. Exhaustive proteolysis of purified IAARh123-labeled 85 and 111 kDa polypeptides revealed one (6 kDa) and two (approximately 6 plus 4 kDa) photolabeled peptides, respectively. Resolution of total tryptic digest of IAARh123-labeled MRP1 by HPLC showed three radiolabeled peaks consistent with the three Staphylococcus aureus V8 cleaved peptides from the Cleveland maps. Together, the results of this study show direct binding of IAARh123 to three sites that localize to the N- and C-domains of MRP1. Moreover, IAARh123 provides a sensitive and specific probe to study MRP1-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112520     DOI: 10.1021/bi0020574

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin.

Authors:  Marjan Afrouzian; Rabab Al-Lahham; Svetlana Patrikeeva; Meixiang Xu; Valentina Fokina; Wayne G Fischer; Sherif Z Abdel-Rahman; Maged Costantine; Mahmoud S Ahmed; Tatiana Nanovskaya
Journal:  Biochem Pharmacol       Date:  2018-09-12       Impact factor: 5.858

2.  Photoaffinity labeling of the multidrug resistance protein 2 (ABCC2/cMOAT) with a photoreactive analog of LTC(4).

Authors:  Mara L Leimanis; Joel Karwatsky; Elias Georges
Journal:  Int J Biochem Mol Biol       Date:  2010-12-15

3.  Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.

Authors:  Christian Gauthier; Sandra Weber; Anne-Marie Alarco; Omar Alqawi; Roni Daoud; Elias Georges; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells.

Authors:  Yunliang Chen; Michael Scully; Gloria Petralia; Ajay Kakkar
Journal:  Cancer Biol Ther       Date:  2013-11-19       Impact factor: 4.742

5.  Localization of the GSH-dependent photolabelling site of an agosterol A analog on human MRP1.

Authors:  Xiao-Qin Ren; Tatsuhiko Furukawa; Shunji Aoki; Tomoyuki Sumizawa; Misako Haraguchi; Xiao-Fang Che; Motomasa Kobayashi; Shin-ichi Akiyama
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

6.  Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.

Authors:  Omar Alqawi; Susan Bates; Elias Georges
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

7.  Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).

Authors:  Chantarawan Saengkhae; Chatchanok Loetchutinat; Arlette Garnier-Suillerot
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

8.  Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.

Authors:  Eric Hosy; Renaud Dérand; Jean Revilloud; Michel Vivaudou
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

9.  Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.

Authors:  Han Li; Zhang Yan; Wang Ning; Guo Xiao-Juan; Zang Cai-Hong; Jiang Jin-Hua; Ma Fang; Wang Qing-Duan
Journal:  J Biomed Biotechnol       Date:  2011-06-30

10.  Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach.

Authors:  Jostein Malmo; Axel Sandvig; Kjell M Vårum; Sabina P Strand
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.